Showing results (61-70 of 526) with videos related to
Sort By:
Pageof 53
Canadian Anaesthetists' Society Journal|January 1, 1982
The fate of phenobarbitone in children in hypothermia and at normal body temperatureD Kadar, B K Tang, A W ConnPharmacogenetics|April 1, 1992
Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1L Gu, F J Gonzalez, W Kalow, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1988
Metabolism of diazepam in vitro by human liver. Independent variability of N-demethylation and C3-hydroxylationT Inaba, A Tait, M Nakano, et al.Pharmacogenetics|October 1, 1995
Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepamM Patel, B K Tang, D M Grant, et al.European Journal of Clinical Pharmacology|January 1, 1997
Interindividual variation in the enzymatic 15-keto-reduction of 13,14-dihydro-15-keto-prostaglandin E1 in human liver and in human erythrocytesP Rady-Pentek, R Mueller, B K Tang, et al.Biochemical Pharmacology|February 21, 1997
Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafroleA Pastrakuljic, B K Tang, E A Roberts, et al.Biochemical Pharmacology|June 1, 1997
Interactions of amphetamine analogs with human liver CYP2D6D Wu, S V Otton, T Inaba, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Oxazepam as a probe of hepatic metabolism in patients with Alzheimer's diseaseM Fisman, T Inaba, W Kalow, et al.Canadian Journal of Physiology and Pharmacology|July 1, 1984
A human cytochrome P-450 characterized by inhibition studies as the sparteine-debrisoquine monooxygenaseT Inaba, M Nakano, S V Otton, et al.Canadian Journal of Physiology and Pharmacology|October 1, 1980
Species differences of amobarbital metabolism: dihydroxyamobarbital formationB K Tang, A A Grey, P A Reilly, et al.Pageof 53